Concepedia

Bing Chen

BC

Statistics

Publications

52

Citations

4.3K

H-Index

31

Active since

2003

Affiliations

Qilu Hospital of Shandong University(Current)

Shandong University

Shandong Tumor Hospital

Shandong First Medical University

Mianyang Central Hospital

Bing Chen is an author at Qilu Hospital of Shandong University specializing in molecular oncology, oncology, and medicine.

ORCID

Publications per year

2003–2025

52

Publications

52

circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer

Yuting Sang, Bing Chen, Xiaojin Song et al. · Molecular Therapy · 2019 · 516 citations · Full text

, , +17

RETRACTED ARTICLE: LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis

Yiran Liang, Xiaojin Song, Yaming Li et al. · Molecular Cancer · 2020 · 396 citations · Full text

, , +17

SREBP1, targeted by miR-18a-5p, modulates epithelial-mesenchymal transition in breast cancer via forming a co-repressor complex with Snail and HDAC1/2

Ning Zhang, Hanwen Zhang, Ying Liu et al. · Cell Death and Differentiation · 2018 · 234 citations · Full text

, , +16

CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR

Xiaolong Wang, Tong Chen, Chen Li et al. · Journal of Hematology & Oncology · 2022 · 230 citations · Full text

, , +17

Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28

Bing Chen, Yuting Sang, Xiaojin Song et al. · Theranostics · 2021 · 214 citations · Full text

, , +17

1–5 of 52